Abstract
Toxicokinetics and toxicodynamics vary depending on dose, developmental stage and exposure timing. The embryo is the developmental stage most susceptible to toxicants. Many birth defects occur only as a result of first trimester exposures when organogenesis is occurring and the formation of new organs and structures (e.g., limbs) can be disrupted. The Absorption, Distribution, Metabolism and Elimination (ADME) of toxicants changes dramatically as the embryo grows from a single-celled organism into a fetus with multiple organ systems. Before birth the mother’s behavior and body largely determines the toxicokinetics of chemicals. Immediately after birth the newborn’s organs must suddenly function independently of the mother. Birth itself is a major trigger causing widespread changes in gene and protein expression patterns. The average infant doubles in size in under a year’s time, the first of roughly four doublings in size after birth. Toddlers’ mobility and mouthing behavior put them at greatest risk for accidental poisonings. Older children’s growth and development makes their metabolism unpredictable. Adolescents develop adult metabolic capacity but adolescent behavior can make them more likely to abuse some toxicants (e.g., inhalants). ADME changes as pregnancy progresses for adolescents and adults. In general adults are the least susceptible to toxicants but occupation becomes a major risk factor for exposure. Elderly adults become somewhat more susceptible to toxicants as organ function declines with age. Beer’s list, unit doses of iron, and the X classification system are examples of translational toxicology designed to protect elderly patients, toddlers and embryos respectively.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abadi S, Einarson A, Koren G (2002) Use of Warfarin during pregnancy. Can Fam Physician 48(4):695–697
American Red Cross (2014) Blood donor eligibility: blood pressure, pregnancy, disease & more|American Red Cross. [online] Available at: http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-alphabetical-listing. Accessed 10 July 2014
Arimura J, Poole R, Jeng M, Rhine W, Sharek P (2008) Neonatal heparin overdose-a multidisciplinary team approach to medication error prevention. J Pediatr Pharmacol Ther 13(2):96–98
Baird C, Furek M (2012) Adolescents and inhalant abuse: how huffing affects the myelin sheath. J Addict Nurs 23(2):129–131
Bakir F et al (1980) Clinical and epidemiological aspects of methylmercury poisoning. Postgrad Med J 56(651):1–10
Baydala L (2010) Inhalant abuse. Paediatr Child Health 15(7):443–454
Bhat N, Rosato E, Gupta P (1989) Gynecomastia in a mortician. A case report. Acta Cytol 34(1):31–34
Blaner W (2013) The fat-soluble vitamins 100 years later: where are we now? J Lipid Res 54(7):1716–1718
Brust J (2010) Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review. Int J Environ Res Public Health 7(4):1540–1557
CDC (2010) Growth charts 2010. http://www.cdc.gov/growthcharts/cdc_charts.htm. Accessed 3 July 2014
CDC (2014) Botulism. http://www.cdc.gov/nczved/divisions/dfbmd/diseases/botulism/. Accessed 4 July 2014
Cressman A, Pupco A, Kim E, Koren G, Bozzo P (2012) Smoking cessation therapy during pregnancy. Can Fam Physician 58(5):525–527
Croom E, Stevens J, Hines R, Wallace A, Hodgson E (2009) Human hepatic CYP2B6 developmental expression: the impact of age and genotype. Biochem Pharmacol 78(2):184–190
Croom E, Wallace A, Hodgson E (2010) Human variation in CYP-specific chlorpyrifos metabolism. Toxicology 276(3):184–191
Davies J, Dedhia H, Morgade C, Barquet A, Maibach H (1983) Lindane poisonings. Arch Dermatol 119(2):142–144
FDA (2013) THALOMID® Risk evaluation and mitigation strategy (REMS)
Franzman M, Levy S, Warren J, Broffitt B (2006) Fluoride dentifrice ingestion and fluorosis of the permanent incisors. J Am Dent Assoc 137(5):645–652
Harrington J, Stein G, Rivera R, de Morales A (1978) The occupational hazards of formulating oral contraceptives – a survey of plant employees. Arch Environ Health 33(1):12–15
Hayes W (1982) Pesticides studied in man, 1st edn. Williams & Wilkins, Baltimore, pp 211–228
Hines R (2008) The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118(2):250–267
Judson R, Martin M, Egeghy P, Gangwal S, Reif D, Kothiya P, Wolf M, Cathey T, Transue T, Smith D, and others (2012) Aggregating data for computational toxicology applications: the US environmental protection agency (ePA) Aggregated Computational toxicology Resource (ACtoR) system. Int J Mol Sci 13(2):1805–1831
Kim J, Scialli A (2011) Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol Sci 122(1):1–6
Knobeloch L, Salna B, Hogan A, Postle J, Anderson H (2000) Blue babies and nitrate-contaminated well water. Environ Health Perspect 108(7):675
Köhler T, Kondapalli L, Shah A, Chan S, Woodruff T, Brannigan R (2011) Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet 28(3):269–277
Koren G, Pairaideau N (2006) Compliance with prenatal vitamins. Patients with morning sickness sometimes find it difficult. Can Fam Physician 52(11):1392–1393
Koukouritaki S, Manro J, Marsh S, Stevens J, Rettie A, McCarver D, Hines R (2004) Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 308(3):965–974
Lawlor F, Peiris S (1985) Progress of a harlequin fetus treated with etretinate. J R Soc Med 78(Suppl 11):19
Lebel C, Roussotte F, Sowell E (2011) Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain. Neuropsychol Rev 21(2):102–118
Lipinski RJ et al (2012) Ethanol-induced face-brain dysmorphology patterns are correlative and exposure-stage dependent. PLoS One 7(8):e43067
Maier S, West J (2001) Drinking patterns and alcohol-related birth defects. Alcohol Res Health 25(3):168
Monagle (2008) Antithrombotic therapy in neonates and children. Chest 133.6 suppl (2008):887S
Morris C (2000) Pediatric iron poisonings in the United States. South Med J 93(4):352–358
Monagle P, Studdert D, Newall F (2012) Infant deaths due to heparin overdose: time for a concerted action on prevention. J Paediatr Child Health 48(5):380–381
Sanchez-Echaniz J, Benito-Fern’andez J, Mintegui-Raso S (2001) Methemoglobinemia and consumption of vegetables in infants. Pediatrics 107(5):1024–1028
Selevan S, Kimmel C, Mendola P (2000) Identifying critical windows of exposure for children’s health. Environ Health Perspect 108(Suppl 3):451
Solomon G, Moodley J (2007) Acute chlorpyrifos poisoning in pregnancy: a case report. Clin Toxicol 45(4):416–419
Stevens J, Hines R, Gu C, Koukouritaki S, Manro J, Tandler P, Zaya M (2003) Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307(2):573–582
Talhout R, Schulz T, Florek E, Van Benthem J, Wester P, Opperhuizen A (2011) Hazardous compounds in tobacco smoke. Int J Environ Res Public Health 8(2):613–628
Tenenbein M (2005) Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med 159(6):557–560
Teratology Society (1987) Teratology society position paper: recommendations for vitamin A use during pregnancy. Teratology 35:269–275
Therapontos C, Erskine L, Gardner E, Figg W, Vargesson N (2009) Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci 106(21):8573–8578
Waters M, Stack H, Garrett N, Jackson M (1991) The genetic activity profile database. Environ Health Perspect 96:41
Wickström R (2007) Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol 5(3):213
Wishart D, Knox C, Guo A, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(suppl 1):668–672
Wooten J (2012) Pharmacotherapy considerations in elderly adults. South Med J 105(8):437–445
Wu FC (1997) Endocrine aspects of anabolic steroids. Clin Chem 43(7):1289–1292
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Croom, E.L. (2016). The Role of Toxicokinetics and Toxicodynamics in Developmental and Translational Toxicology. In: Hughes, C., Waters, M. (eds) Translational Toxicology. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-27449-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-27449-2_2
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-27447-8
Online ISBN: 978-3-319-27449-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)